Color Genomics IPO
Color Genomics provides genetic testing and telehealth services focused on hereditary cancer, heart health, and medication response. The company has built a platform combining genetic testing with clinical-grade telehealth consultations, making personalized medicine more accessible to consumers and healthcare providers.
Key Facts
| Industry | Biotechnology |
| Founded | 2013 |
| Headquarters | Burlingame, CA |
| Employees | ~400 |
| Website | color.com |
| Funding | Series D at $4.6B valuation. Total raised: ~$278M |
About Color Genomics
Color Genomics is a population health technology company that provides genetic testing and screening services primarily focused on hereditary cancer and cardiac conditions. The company offers comprehensive genetic testing panels that help identify individuals at risk for conditions like BRCA-related cancers, Lynch syndrome, and familial hypercholesterolemia. Color has built a platform that combines genetic testing with clinical-grade interpretation and genetic counseling services.
The company has differentiated itself by focusing on making genetic testing accessible at scale through partnerships with health systems, employers, and life insurers. Color's approach emphasizes population-level screening rather than individual consumer testing, working with organizations like the Department of Veterans Affairs and various health plans to implement large-scale genetic screening programs. Their technology platform integrates genetic testing with clinical workflows and provides actionable insights for both patients and healthcare providers.
IPO Status
Color Genomics remains a private company with no confirmed IPO plans announced publicly. The company has raised significant venture funding over the years, including partnerships with major health systems and employers to provide genetic testing services. While the genomics and personalized medicine sector has seen IPO activity from competitors, Color has not disclosed any specific timeline or intentions regarding going public. The company continues to focus on expanding its testing capabilities and partnerships in the healthcare sector.
Competitors
Frequently Asked Questions
Does Color Genomics have a stock?
No, Color Genomics has not had an IPO yet. The company remains privately held with no confirmed public offering announced.
When is the Color Genomics IPO date?
There is no confirmed IPO date for Color Genomics. The company has not announced any plans to go public.
How can I buy Color Genomics stock?
You cannot currently buy Color Genomics stock as it is a private company. If they announce IPO plans in the future, shares would become available through brokers.
Stay Updated on the Color Genomics IPO
Get real-time alerts when Color Genomics files for an IPO, prices shares, or begins trading.
Get IPO Alerts